| human | Q5 |
| P6178 | Dimensions author ID | 01034161762.55 |
| P496 | ORCID iD | 0000-0001-5926-5677 |
| P3829 | Publons author ID | 1690940 |
| P1053 | ResearcherID | I-2567-2017 |
| P108 | employer | University of Navarre | Q926068 |
| P734 | family name | Ravassa | Q55095795 |
| Ravassa | Q55095795 | ||
| Ravassa | Q55095795 | ||
| P735 | given name | Susana | Q14936073 |
| Susana | Q14936073 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q41575826 | A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population |
| Q61984455 | Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats |
| Q40485505 | Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir |
| Q39139430 | Annexin A5 in treated hypertensive patients and its association with target organ damage |
| Q39600857 | Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes |
| Q61984451 | Apoptosis in hypertensive heart disease |
| Q36497901 | Apoptosis in hypertensive heart disease: a clinical approach |
| Q48153967 | Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients |
| Q53275228 | Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. |
| Q53526276 | Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. |
| Q38919256 | Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: a pilot study |
| Q37258076 | Biochemical markers of myocardial remodelling in hypertensive heart disease |
| Q52803941 | Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial |
| Q53574768 | Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study. |
| Q90907042 | CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation |
| Q39693956 | Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. |
| Q35538421 | Cardiomyocyte apoptosis in hypertensive cardiomyopathy |
| Q64109352 | Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload |
| Q37993729 | Cardiotrophin-1 in hypertensive heart disease |
| Q64239235 | Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population |
| Q38517255 | Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal. |
| Q91239773 | Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease |
| Q57395355 | Clinical implications of apoptosis in hypertensive heart disease |
| Q92682482 | Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation |
| Q57395337 | Contribution of circulating biomarkers to unravel the role of extracellular matrix in hypertensive cardiac remodelling |
| Q36222011 | Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population. |
| Q38048960 | Glucagon-like peptide 1 and cardiac cell survival |
| Q56962478 | Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis |
| Q57455375 | Increased fibroblast growth factor 23 in heart failure: Biomarker, mechanism or both? |
| Q47644833 | Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). |
| Q42848160 | Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling? |
| Q61687952 | Mechanisms of Increased Susceptibility to Angiotensin II–Induced Apoptosis in Ventricular Cardiomyocytes of Spontaneously Hypertensive Rats |
| Q37623540 | Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites. |
| Q42330259 | MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure |
| Q40959309 | Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure |
| Q57822874 | Myocardial Remodeling in Hypertension |
| Q37948286 | New targets to treat the structural remodeling of the myocardium |
| Q40091740 | Novel Urinary Peptidomic Classifier Predicts Incident Heart Failure |
| Q51040164 | Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? |
| Q61984453 | Overexpression of Bax Protein and Enhanced Apoptosis in the Left Ventricle of Spontaneously Hypertensive Rats |
| Q39987669 | Overexpression of human truncated peroxisome proliferator-activated receptor alpha induces apoptosis in HL-1 cardiomyocytes |
| Q51115274 | Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome. |
| Q51511438 | Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients. |
| Q48024326 | Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. |
| Q50215743 | Role of Myocardial Collagen in Severe Aortic Stenosis With Preserved Ejection Fraction and Symptoms of Heart Failure |
| Q43859248 | Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. |
| Q39018913 | The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes |
| Q37366826 | The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus |
| Q61984445 | Torasemide Inhibits Angiotensin II–Induced Vasoconstriction and Intracellular Calcium Increase in the Aorta of Spontaneously Hypertensive Rats |
| Q57395338 | Towards the molecular diagnosis of hypertensive heart disease? |
| Q57395330 | Understanding the Role of CCN Matricellular Proteins in Myocardial Fibrosis ∗ |
| Q57395348 | Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction |
| Q38688400 | Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction |
| Q61984450 | [Apoptosis in hypertensive cardiopathy] |
| Q61687940 | [Vascular oxidative stress and endothelial dysfunction] |
| Q61984447 | p53-Mediated Upregulation of BAX Gene Transcription Is Not Involved in Bax-α Protein Overexpression in the Left Ventricle of Spontaneously Hypertensive Rats |
Search more.